Lymphodepletion can eradicate suppressive immune cells in the host, including Tregs and myeloid-derived suppressor cells22–24, and the repopulation of tumor-specific effector T cells significantly exceeded that of Tregs, as the expansion of Tregs was limited by interleukin (IL)-2 availability25. This evidence concerns the gene IL2 and neoplasm.